Development and validation of a rapid UPLC-MS/MS method for quantifying bevacizumab in human plasma and application in Chinese cancer patients
{{output}}
Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, is widely used in the treatment of various cancers. Despite its efficacy, the drug exhibits significant interindividual variability in pharmacokinetics and clinical response. This... ...
